to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban

NCT07265466 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Drug Interaction (DDI)

Interventions

DRUG: JP-1366 and clopidogrel
DRUG: JP-1366 and aspirin
DRUG: JP-1366 and atorvastatin
DRUG: JP-1366 and apixaban

Sponsor

Onconic Therapeutics Inc.